Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Filings indexed 1,291 across all filing types
Latest filing 2016-08-10 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
首次公开发行股票招股意向书摘要
Capital/Financing Update Classification · 95% confidence The document is titled as "郑州安图生物工程股份有限公司首次公开发行股票并上市申请文件 招股意向书摘要" which translates to "Autobio Diagnostics Co., Ltd. Initial Public Offering (IPO) and Listing Application Document - Prospectus Summary." The content includes detailed information about the company's IPO, including share issuance, underwriting, shareholder commitments, risk factors, tax policies, and investment projects. It is clearly an IPO prospectus or offering document, which is a type of capital raising and financing update. The document is lengthy (15,000 characters) and contains substantive information about the issuance and listing process, not just an announcement or summary. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2016-08-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.